Paul Balmer
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 30, 2025
A Phase 3B, Open-Label Study to Evaluate the Immunogenicity and Safety of the Quadrivalent Meningococcal Nimenrix® Vaccine When Given to Healthy Infants at 3 and 12 Months of Age.Susanna Koski, Federico Martinon-Torres, Mika Rämet
|Dec 05, 2024
Global epidemiology of serogroup Y invasive meningococcal disease: a literature review.Myint Tin Tin Htar, Jamie Findlow, Paul Balmer
|Apr 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage.Jamie Findlow, Ray Borrow, David S Stephens
|Jul 21, 2021
Correlates of protection for meningococcal surface protein vaccines: lessons from the past.Jamie Findlow, Jay Lucidarme, Muhamed-Kheir Taha
|Feb 22, 2021
Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States.Liping Huang, Sonya J Snedecor, Paul Balmer
Pageof 1
Frequent Collaborators
4 joint publications
Jamie Findlow
1 joint publications
Liping Huang
1 joint publications
Sonya J Snedecor
1 joint publications
Amit Srivastava
1 joint publications
Jay Lucidarme
1 joint publications
Muhamed-Kheir Taha
1 joint publications
Ray Borrow
1 joint publications
Myint Tin Tin Htar
1 joint publications
David Swerdlow
1 joint publications
Susanna Koski
